The findings are consistent with international research; adults with ADHD in New Zealand have higher rates of psychiatric disorders than the general population.
The aim of this study was to explore whether individuals with attention-deficit/hyperactivity disorder (ADHD) are at risk of harm over the lifespan due to increased rates of self-harm, suicidal ideation and suicidal behaviour, and whether this association is mediated by psychosocial factors. Sixty-six adults (43 men, 23 women; 18-65 years) participated in this study involving clinical interview and retrospective self-report measures of ADHD symptoms, self-harm/suicidal behaviour, mental health disorders, and coping style measures. Significant associations were found between ADHD symptom severity and self-reported histories of self-harm behaviour, suicidal ideation, and suicide attempts (all p values<.05). These relationships between self-destructive behaviours and ADHD symptom severity were found to be significantly and differentially mediated by psychosocial variables (all p values<.05) including comorbidity (mood, anxiety, drug, and alcohol abuse disorders) and emotion-focussed coping style. This study suggests that linkages between self-injurious behaviour and ADHD symptomatology may be due primarily to comorbid mental health disorders and emotion-focussed coping. The identification of these mediating factors and processes may potential pathways for intervention in reducing suicide and self-harm risk amongst those with ADHD symptoms.
Although this study, as an open trial, does not in itself prove efficacy, it provides preliminary evidence supporting the need for a randomized clinical trial of micronutrients as treatment for the more complex presentations of ADHD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.